OUTLOOK THERAPEUTICS, INC. |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 7.9 USD | +4.91% |
|
+1.54% | +0.25% |
| 05-21 | CoStar Group has room for expansion |  |
| 05-16 | Transcript : Outlook Therapeutics, Inc., Q2 2024 Earnings Call, May 16, 2024 |
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
End-of-day quotes
End-of-day quotes
Sector Other Biotechnology & Medical Research
| Capi. | Sales growth | Profitability | Finances | EV / Sales | P/E ratio | |
|---|---|---|---|---|---|---|
| 185M | - | - | - | - | - | |
| 63.85B | - | |||||
| 41.83B | ||||||
| 40.65B | ||||||
| 27.12B | ||||||
| 26.52B |
